ACS Nano | Engineering self-activating polymer nanoenzymes precisely eliminate bacteria within tumor-associated macrophages to enhance immunotherapy based on the blockade of differentiation cluster 47
QQ Academic Group: 1092348845

Detailed

Immunotherapy for colorectal cancer (CRC) is still clinically limited by the extremely immunosuppressive tumor microenvironment. Fusobacterium nucleatum (Fn) selectively colonizes CRC

Copyright © beijing beike new material Technology Co., Ltd 京ICP备16054715-2号